BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9217862)

  • 1. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rocuronium-cisatracurium combinations.
    Donati F; Plaud B
    Anesthesiology; 1999 Aug; 91(2):587-8. PubMed ID: 10443637
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination.
    Naguib M; Samarkandi AH; Ammar A; Elfaqih SR; Al-Zahrani S; Turkistani A
    Anesthesiology; 1998 Nov; 89(5):1116-24. PubMed ID: 9821999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming with rocuronium to accelerate the onset time of cisatracurium during intubation.
    Lin SP; Chang KY; Chen YJ; Lin SM; Chang WK; Chan KH; Ting CK
    J Chin Med Assoc; 2009 Jan; 72(1):15-9. PubMed ID: 19181592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose rocuronium and tracheal intubation.
    Naguib M; Kopman AF
    Middle East J Anaesthesiol; 2003 Jun; 17(2):193-204. PubMed ID: 14503121
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cisatracurium and rocuronium on cisatracurium precurarization and the priming principle.
    Mak PH; Irwin MG
    J Clin Anesth; 2004 Mar; 16(2):83-7. PubMed ID: 15110367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia.
    Fodale V; Praticò C; Santamaria LB
    Eur J Anaesthesiol; 2004 Apr; 21(4):333-4; author reply 334-5. PubMed ID: 15109204
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.